GSK

GlaxoSmithKline is leaning into genetics for its next chapter of getting and developing medicine.  The pharma large is doing work with teams like 23andMe and Jennifer Doudna’s new laboratory. GSK’s John Lepore informed Insider how genetics exploration resurrected a floundering experimental drug. The drug was floundering.  After a decade in […]